• The lancet oncology · Mar 2023

    Review

    Systematic review and updated recommendations for cardiomyopathy surveillance for survivors of childhood, adolescent, and young adult cancer from the International Late Effects of Childhood Cancer Guideline Harmonization Group.

    • Matthew J Ehrhardt, Jan M Leerink, Renée L Mulder, Annelies Mavinkurve-Groothuis, Wouter Kok, Anju Nohria, Paul C Nathan, Remy Merkx, Esmée de Baat, Ogechukwu A Asogwa, Roderick Skinner, Hamish Wallace, E A M Lieke Feijen, Maëlle de Ville de Goyet, Maya Prasad, Edit Bárdi, Vesna Pavasovic, Helena van der Pal, Brice Fresneau, Charlotte Demoor-Goldschmidt, Ulrike Hennewig, Julia Steinberger, Chris Plummer, Ming Hui Chen, Arco J Teske, Nadia Haddy, Elvira C van Dalen, Louis S Constine, Eric J Chow, Gill Levitt, Melissa M Hudson, KremerLeontien C MLCMPrincess Máxima Center for Pediatric Oncology, Utrecht, Netherlands; Emma Children's Hospital, Amsterdam UMC, Amsterdam, Netherlands., and Saro H Armenian.
    • Department of Oncology and Department of Epidemiology and Cancer Control, St Jude Children's Research Hospital, Memphis, TN, USA. Electronic address: matthew.ehrhardt@stjude.org.
    • Lancet Oncol. 2023 Mar 1; 24 (3): e108e120e108-e120.

    AbstractSurvivors of childhood, adolescent, and young adult cancer, previously treated with anthracycline chemotherapy (including mitoxantrone) or radiotherapy in which the heart was exposed, are at increased risk of cardiomyopathy. Symptomatic cardiomyopathy is typically preceded by a series of gradually progressive, asymptomatic changes in structure and function of the heart that can be ameliorated with treatment, prompting specialist organisations to endorse guidelines on cardiac surveillance in at-risk survivors of cancer. In 2015, the International Late Effects of Childhood Cancer Guideline Harmonization Group compiled these guidelines into a uniform set of recommendations applicable to a broad spectrum of clinical environments with varying resource availabilities. Since then, additional studies have provided insight into dose thresholds associated with a risk of asymptomatic and symptomatic cardiomyopathy, have characterised risk over time, and have established the cost-effectiveness of different surveillance strategies. This systematic Review and guideline provides updated recommendations based on the evidence published up to September, 2020.Copyright © 2023 Elsevier Ltd. All rights reserved.

      Pubmed     Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…